PreprintAll rights reservedmedRxiv
Biomarker Convert: a novel approach to transform plasma pTau217 results across immunoassay and mass spectrometry analytical platforms
- 1Prothena Biosciences
Related
- Identifying and resolving analytical outliers in lipoprotein(a) immunoassay testing
- Analytical validation and amyloid-status discrimination of a high-throughput, research-use-only plasma p-Tau217 immunoassay
- Validation of plasma biomarker immunoassay‐based models for predicting brain amyloid positivity in cognitively impaired individuals
- Analytical validation of a MALDI-TOF mass spectrometry method for serum IGF-1 measurement and its comparison with LC-MS/MS and CLIA
- Analytical performance of a delayed-centrifugation blood collection tube for remote blood biomarker assessment
BibTeX
@misc{quadrini2026biomarker,
title = {{Biomarker Convert: a novel approach to transform plasma pTau217 results across immunoassay and mass spectrometry analytical platforms}},
author = {K. J. Quadrini and J. Aubrecht and F. Vernhes and X. Zeng and A. D. Johnson and B. E. Snitz and A. D. Cohen and R. Tooker and M. E. Quiceno and B. M. Campbell and T. K. Karikari and C. J. Swanson},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.28.26363900},
url = {https://www.medrxiv.org/content/10.64898/2026.09.28.26363900v1},
}
RIS
TY - UNPB
TI - Biomarker Convert: a novel approach to transform plasma pTau217 results across immunoassay and mass spectrometry analytical platforms
AU - K. J. Quadrini
AU - J. Aubrecht
AU - F. Vernhes
AU - X. Zeng
AU - A. D. Johnson
AU - B. E. Snitz
AU - A. D. Cohen
AU - R. Tooker
AU - M. E. Quiceno
AU - B. M. Campbell
AU - T. K. Karikari
AU - C. J. Swanson
PY - 2026
DA - 2026/09/28
PB - medRxiv
DO - 10.64898/2026.09.28.26363900
UR - https://www.medrxiv.org/content/10.64898/2026.09.28.26363900v1
ER -